RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM: PROJECT NO 5218 MATMACORP SARS-COV-2 HIGH THROUGHPUT LABORATORY CAPACITY SCALE-UP

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N92020C00019-P00002-9999-1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020.0
    2021.0
  • Known Financial Commitments (USD)

    $4,947,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    . PHIL KOZERA
  • Research Location

    United States of America
  • Lead Research Institution

    MATERIALS/ MACHINES CORPORATION/AMERICA
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

MatMaCorp is an animal health diagnostics company that collaborates with agencies including the Department of Homeland Security (DHS) Science and Technology group and USDA's Meat Animal Research Center (USMARC). In February of 2020, we shifted focus to human health in response to the COVID-19 pandemic. We are working to utilize our portable diagnostic platform, the Solas 8 fluorescent detection device and proprietary tests, with features supportive of rapid, mobile human diagnostics. Our device uses molecular probes to detect and identify specific DNA or RNA (target) sequences, in addition to a mutation or variation (SNP) within a sequence.  Additional Features: ·       Touchscreen interface ·       USB Ports ·       Wi-Fi enabled ·       Mobile Application ·       Automated calling of results   Additionally, our assays are lyophilized and do not require pipettes, centrifuges, or refrigeration and have a twelve-month shelf life. The Covid-19 kits are made for lab-use or field-use, providing flexibility and accessibility. Whether at a workplace, in a lab, or in a mobile testing center, results can be generated in real-time without specialized lab equipment, technical skills, or controlled conditions.